William Blair Comments on Astrana Health Q2 Earnings

Astrana Health, Inc. (NASDAQ:ASTH) – Analysts at William Blair issued their Q2 2026 earnings per share estimates for Astrana Health in a research note issued on Wednesday, July 2nd. William Blair analyst R. Daniels forecasts that the company will post earnings of $0.45 per share for the quarter. The consensus estimate for Astrana Health’s current full-year earnings is $1.15 per share. William Blair also issued estimates for Astrana Health’s Q3 2026 earnings at $0.46 EPS.

Astrana Health (NASDAQ:ASTH) last posted its earnings results on Thursday, May 8th. The company reported $0.14 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.23 by ($0.09). The business had revenue of $620.39 million for the quarter, compared to analyst estimates of $628.11 million. Astrana Health had a return on equity of 4.90% and a net margin of 1.56%. The firm’s revenue for the quarter was up 53.4% compared to the same quarter last year. During the same period last year, the company posted $0.31 EPS.

A number of other brokerages have also recently weighed in on ASTH. Truist Financial decreased their price target on shares of Astrana Health from $50.00 to $46.00 and set a “buy” rating for the company in a research report on Tuesday, March 18th. Barclays began coverage on Astrana Health in a research note on Tuesday, April 1st. They set an “equal weight” rating and a $36.00 price objective on the stock. Three research analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $53.29.

Astrana Health Price Performance

Astrana Health stock opened at $25.28 on Friday. The firm has a fifty day moving average of $26.65 and a 200-day moving average of $30.73. Astrana Health has a 52-week low of $23.12 and a 52-week high of $63.20. The company has a quick ratio of 1.70, a current ratio of 1.70 and a debt-to-equity ratio of 0.54. The firm has a market capitalization of $1.42 billion, a P/E ratio of 35.10, a PEG ratio of 1.36 and a beta of 0.84.

Institutional Trading of Astrana Health

A number of hedge funds and other institutional investors have recently modified their holdings of ASTH. Quarry LP increased its stake in shares of Astrana Health by 35.5% in the fourth quarter. Quarry LP now owns 1,799 shares of the company’s stock worth $57,000 after buying an additional 471 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its position in shares of Astrana Health by 3.9% in the 4th quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 24,505 shares of the company’s stock worth $773,000 after purchasing an additional 915 shares during the last quarter. Swiss National Bank increased its position in shares of Astrana Health by 1.1% in the 4th quarter. Swiss National Bank now owns 88,444 shares of the company’s stock worth $2,789,000 after purchasing an additional 1,000 shares during the last quarter. US Bancorp DE raised its stake in shares of Astrana Health by 21.3% in the 1st quarter. US Bancorp DE now owns 5,791 shares of the company’s stock valued at $180,000 after purchasing an additional 1,015 shares in the last quarter. Finally, MetLife Investment Management LLC lifted its position in shares of Astrana Health by 4.7% during the fourth quarter. MetLife Investment Management LLC now owns 26,284 shares of the company’s stock worth $829,000 after purchasing an additional 1,173 shares during the last quarter. 52.77% of the stock is owned by hedge funds and other institutional investors.

About Astrana Health

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.